Agree, but I think the $1B+ MC can't be achieved without FDA approval......maybe $200M. With the worst case where RAP is required to redo the clinical trials (provided that the FDA didn't reject the application due to efficacy), but target Adult first and make sure there are a panel of adjudicators this time given now they know what the US is like.
Should i buy RAP at 8c ??, page-8
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
